Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

14-01-2019 | Rheumatoid arthritis | Highlight | News

Trial results support management of cardiovascular risk factors in RA patients

Managing traditional cardiovascular risk factors with a treat-to-target approach slows progression of subclinical atherosclerosis among patients with rheumatoid arthritis, suggest results from the FRANCIS trial.

The importance of early diagnosis and treatment of inflammatory arthritis

In this Medicine Matters rheumatology podcast, we talk to President-Elect of EULAR Professor Iain McInnes, about the importance of early diagnosis and treatment of rheumatic diseases.

11-01-2019 | Psoriatic arthritis | Editorial | Article

Screening psoriasis patients for development of psoriatic arthritis

Vinod Chandran discusses recent developments in screening tools for identifying patients with psoriatic arthritis, and those who are at high risk for developing this disease.

Latest from across the site

15-01-2019 | ANCA-associated vasculitis | News

Randomized data back EULAR guidelines for mycophenolate mofetil use in AAV

Mycophenolate mofetil is noninferior to cyclophosphamide for inducing remission among patients with antineutrophil cytoplasmic antibody-associated vasculitis, randomized trial data show.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-214245

14-01-2019 | Rheumatoid arthritis | Highlight | News

Trial results support management of cardiovascular risk factors in RA patients

Managing traditional cardiovascular risk factors with a treat-to-target approach slows progression of subclinical atherosclerosis among patients with rheumatoid arthritis, suggest results from the FRANCIS trial.

Source:

Ann Rheum Dis 2019; doi:10.1136/annrheumdis-2018-214075

11-01-2019 | Psoriatic arthritis | Editorial | Article

Screening psoriasis patients for development of psoriatic arthritis

Vinod Chandran discusses recent developments in screening tools for identifying patients with psoriatic arthritis, and those who are at high risk for developing this disease.

Author:
Vinod Chandran

11-01-2019 | Juvenile idiopathic arthritis | News

News in brief

Predictors of outcomes identified in JIA-associated uveitis

Demographic factors, measures of disease activity, and the type of treatment used are associated with 2-year outcomes among patients with juvenile idiopathic arthritis-associated uveitis, according to findings from the ICON-JIA study.

10-01-2019 | Rheumatoid arthritis | News

Biologic combination therapy for RA may increase risk for side effects

Findings from a systematic review and meta-analysis suggest that rheumatoid arthritis patients who receive combination therapy with two biologic DMARDs are more likely to experience adverse events than those given one biologic.

Source:

Semin Arthritis Rheum 2018; doi:10.1016/j.semarthrit.2018.12.003

09-01-2019 | Rheumatoid arthritis | News

Serious infection risk similar among non-TNF inhibitor biologics in RA

Study findings do not support the use of one non-tumor necrosis factor inhibitor biologic DMARD over another when considering the risk for serious infection in patients with rheumatoid arthritis.

Source:

Ann Rhuem Dis 2018; doi:10.1136/annrheumdis-2018-214326

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits